Fuchs’ Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis

Purpose. To study epidemiology, clinical findings and visual prognosis of patients with Fuchs’ Heterochromic Iridocyclitis (FHI). Methods. A retrospective analysis was performed on 158 patients with FHI. Thirty-five patients were observed only once; the remaining 123 had a mean follow-up of 30.7 mon...

Full description

Saved in:
Bibliographic Details
Main Authors: Massimo Accorinti, Giovanni Spinucci, Maria Pia Pirraglia, Simone Bruschi, Francesca Romana Pesci, Ludovico Iannetti
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2016/1458624
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557109275787264
author Massimo Accorinti
Giovanni Spinucci
Maria Pia Pirraglia
Simone Bruschi
Francesca Romana Pesci
Ludovico Iannetti
author_facet Massimo Accorinti
Giovanni Spinucci
Maria Pia Pirraglia
Simone Bruschi
Francesca Romana Pesci
Ludovico Iannetti
author_sort Massimo Accorinti
collection DOAJ
description Purpose. To study epidemiology, clinical findings and visual prognosis of patients with Fuchs’ Heterochromic Iridocyclitis (FHI). Methods. A retrospective analysis was performed on 158 patients with FHI. Thirty-five patients were observed only once; the remaining 123 had a mean follow-up of 30.7 months (50 of them had a mean follow-up of 63.5 months) and in those we assessed complications, medical and surgical treatment, and long-term visual prognosis. Results. Average age at uveitis diagnosis was 27.2 years and 18.3% of patients were children. Blurred vision (54.5%) and floaters (40.5%) were the most frequent presenting symptoms. Small to medium-sized keratic precipitates (95.6%), iris atrophy (86.8%), and vitreous opacities (91.2%) were the most common signs; the prevalence of cataract and IOP increase was 63.5% and 20.1%, respectively, and their incidence was 0.1 and 0.06 eye/year. Significant risk factor for visual loss was IOP increase at presentation (p=0.02). At final examination 98% of the eye had a visual acuity ≥ 0.6, and topical (p<0.001) and systemic (p<0.001) corticosteroids therapy were used less frequently than before referral. Conclusions. FHI has a good visual prognosis, despite the significant incidence of cataract and glaucoma. A correct and prompt diagnosis might avoid unnecessary therapies and provide excellent visual outcomes.
format Article
id doaj-art-7b0b4b4cb5f4439f81a1602d95968298
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-7b0b4b4cb5f4439f81a1602d959682982025-02-03T05:43:39ZengWileyJournal of Ophthalmology2090-004X2090-00582016-01-01201610.1155/2016/14586241458624Fuchs’ Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and PrognosisMassimo Accorinti0Giovanni Spinucci1Maria Pia Pirraglia2Simone Bruschi3Francesca Romana Pesci4Ludovico Iannetti5Department of Ophthalmology, Sapienza University of Rome, Rome, ItalyDepartment of Ophthalmology, Sapienza University of Rome, Rome, ItalyDepartment of Ophthalmology, Sapienza University of Rome, Rome, ItalyDepartment of Ophthalmology, Sapienza University of Rome, Rome, ItalyDepartment of Ophthalmology, Sapienza University of Rome, Rome, ItalyDepartment of Ophthalmology, Sapienza University of Rome, Rome, ItalyPurpose. To study epidemiology, clinical findings and visual prognosis of patients with Fuchs’ Heterochromic Iridocyclitis (FHI). Methods. A retrospective analysis was performed on 158 patients with FHI. Thirty-five patients were observed only once; the remaining 123 had a mean follow-up of 30.7 months (50 of them had a mean follow-up of 63.5 months) and in those we assessed complications, medical and surgical treatment, and long-term visual prognosis. Results. Average age at uveitis diagnosis was 27.2 years and 18.3% of patients were children. Blurred vision (54.5%) and floaters (40.5%) were the most frequent presenting symptoms. Small to medium-sized keratic precipitates (95.6%), iris atrophy (86.8%), and vitreous opacities (91.2%) were the most common signs; the prevalence of cataract and IOP increase was 63.5% and 20.1%, respectively, and their incidence was 0.1 and 0.06 eye/year. Significant risk factor for visual loss was IOP increase at presentation (p=0.02). At final examination 98% of the eye had a visual acuity ≥ 0.6, and topical (p<0.001) and systemic (p<0.001) corticosteroids therapy were used less frequently than before referral. Conclusions. FHI has a good visual prognosis, despite the significant incidence of cataract and glaucoma. A correct and prompt diagnosis might avoid unnecessary therapies and provide excellent visual outcomes.http://dx.doi.org/10.1155/2016/1458624
spellingShingle Massimo Accorinti
Giovanni Spinucci
Maria Pia Pirraglia
Simone Bruschi
Francesca Romana Pesci
Ludovico Iannetti
Fuchs’ Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
Journal of Ophthalmology
title Fuchs’ Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title_full Fuchs’ Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title_fullStr Fuchs’ Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title_full_unstemmed Fuchs’ Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title_short Fuchs’ Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title_sort fuchs heterochromic iridocyclitis in an italian tertiary referral centre epidemiology clinical features and prognosis
url http://dx.doi.org/10.1155/2016/1458624
work_keys_str_mv AT massimoaccorinti fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis
AT giovannispinucci fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis
AT mariapiapirraglia fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis
AT simonebruschi fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis
AT francescaromanapesci fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis
AT ludovicoiannetti fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis